Life Sciences Tools & Services Companies By Current Ratio

Current Ratio
Current RatioEfficiencyMarket RiskExp Return
1SEER Seer Inc
31.07
 0.24 
 2.87 
 0.68 
2AZTA Azenta Inc
13.21
(0.01)
 2.60 
(0.02)
3QTRX Quanterix Corp
11.27
 0.02 
 4.04 
 0.10 
4PACB Pacific Biosciences of
11.19
 0.12 
 6.73 
 0.78 
5BNGO Bionano Genomics
7.75
(0.14)
 5.36 
(0.76)
6NEO NeoGenomics
7.53
 0.08 
 2.66 
 0.21 
7MRVI Maravai Lifesciences Holdings
7.22
(0.07)
 6.24 
(0.46)
8PSNL Personalis
6.26
(0.04)
 5.89 
(0.26)
9CGEN Compugen
6.16
(0.07)
 3.42 
(0.24)
10LAB Standard Biotools
5.87
(0.01)
 4.04 
(0.05)
11TXG 10X Genomics
5.65
(0.10)
 4.61 
(0.47)
12BIO Bio Rad Laboratories
5.5
 0.02 
 2.33 
 0.06 
13CDXS Codexis
4.84
 0.21 
 4.05 
 0.83 
14AXDX Accelerate Diagnostics
4.48
(0.06)
 4.04 
(0.24)
15ADPT Adaptive Biotechnologies Corp
3.93
 0.11 
 5.63 
 0.59 
16GENE Genetic Technologies
3.86
(0.13)
 1.68 
(0.22)
17TECH Bio Techne Corp
3.44
 0.05 
 2.35 
 0.11 
18MLAB Mesa Laboratories
2.9
(0.01)
 3.49 
(0.04)
19SHC Sotera Health Co
2.81
(0.09)
 2.46 
(0.21)
20BRKR Bruker
2.55
(0.06)
 2.68 
(0.16)
The analysis above is based on a 90-day investment horizon and a default level of risk. Use the Portfolio Analyzer to fine-tune all your assumptions. Check your current assumptions here.
Current Ratio is calculated by dividing the Current Assets of a company by its Current Liabilities. It measures whether or not a company has enough cash or liquid assets to pay its current liability over the next fiscal year. The ratio is regarded as a test of liquidity for a company. Typically, short-term creditors will prefer a high current ratio because it reduces their overall risk. However, investors may prefer a lower current ratio since they are more concerned about growing the business using assets of the company. Acceptable current ratios may vary from one sector to another, but the generally accepted benchmark is to have current assets at least as twice as current liabilities (i.e., Current Ration of 2 to 1).